Liesbeth Lenaerts
- Genetics top 10%
- Epidemiology top 10%
- Oncology top 10%
- Molecular Biology
- Infectious Diseases top 10%
- Co-authors
- Lieve NaesensErik De ClercqFrédéric AmantJoris VermeeschAntonı́n HolýJan BalzariniRobert SnoeckGraciela Andreï
- Topics
- Cancer Risks and Factors (12 papers)Virus-based gene therapy research (9 papers)Prenatal Screening and Diagnostics (8 papers)
- Cited by
- GeneticsInfectious DiseasesOncology
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Liesbeth Lenaerts
29 papers receiving 698 citations
Peers
Comparison fields: 5 of 81
- Genetics 337
- Epidemiology 256
- Oncology 234
- Molecular Biology 228
- Infectious Diseases 164
Countries citing papers authored by Liesbeth Lenaerts
This map shows the geographic impact of Liesbeth Lenaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liesbeth Lenaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liesbeth Lenaerts more than expected).
Fields of papers citing papers by Liesbeth Lenaerts
This network shows the impact of papers produced by Liesbeth Lenaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liesbeth Lenaerts. The network helps show where Liesbeth Lenaerts may publish in the future.
Co-authorship network of co-authors of Liesbeth Lenaerts
This figure shows the co-authorship network connecting the top 25 collaborators of Liesbeth Lenaerts. A scholar is included among the top collaborators of Liesbeth Lenaerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liesbeth Lenaerts. Liesbeth Lenaerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 35 | |
| 3 | 6 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 8 | |
| 10 | 65 | |
| 11 | 25 | |
| 12 | 15 | |
| 13 | 1 | |
| 14 | 6 | |
| 15 | 29 | |
| 16 | 14 | |
| 17 | 184 | |
| 18 | 13 | |
| 19 | 83 | |
| 20 | Activity of different classes of nucleoside and nucleotide analogues against adenovirus in cell culture | 1 |
About Liesbeth Lenaerts
Liesbeth Lenaerts is a scholar working on Cancer Research, Oncology and Pediatrics, Perinatology and Child Health, having authored 32 papers that have together received 718 indexed citations. Recurring topics across this work include Cancer Risks and Factors (12 papers), Virus-based gene therapy research (9 papers) and Prenatal Screening and Diagnostics (8 papers). The work is most often cited by research in Genetics (337 citations), Infectious Diseases (164 citations) and Oncology (234 citations). Liesbeth Lenaerts has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Lieve Naesens, Erik De Clercq, Frédéric Amant, Joris Vermeesch, Antonı́n Holý, Jan Balzarini, Robert Snoeck, Graciela Andreï, Charlotte Maggen and Elyce Cardonick. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.